amiea med® - your partner for clinical microneedling
amiea med® Microneedling is a minimally invasive treatment method for activating percutaneous collagen induction (PCI).
amiea med® has developed clinical microneedling for the effective improvement of the aesthetic appearance of acne scars.
Clinical microneedling treatment uses fine needles to create thousands of closely spaced microlesions in the dermis (leather skin). The resulting minimal bleeding activates the release of growth factors via the post-traumatic wound healing cascade, replacing the collagen structures in the scar area with a new subepidermal collagen network (PCI).
In contrast to ablative procedures (e.g. laser resurfacing or chemical peeling) - the upper layers of the skin are not injured over a wide area, but remain intact between the microlesions, so that no structural weakening of the skin occurs. As a result, the recovery phase of the skin after the treatment is very short.
Most advanced (state of the art) device for clinical microneedling
Certificates and registrations:
The proof of quality is the reward for effort.
amiea Med and ibita attach the greatest importance to quality and safety. Both amiea med and ibita are ISO 9001 certified. In addition, MT.DERM GmbH produces under ISO 13485.
ISO 9001 is the basis for quality assurance and quality management.
ISO 13485 is a standard for the requirement of a comprehensive quality management system in the areas of development, production, customer service and assembly of medical devices.
Assembly & Production
MT.DERM produces in Berlin, in a modern factory area of 5200 m2. From design to programming to assembly, every step of the process is owned and therefore under the direct control and responsibility of MT.DERM.
Innovation as a point of performance. Not only the production of high-tech quality products distinguishes MT.DERM but also the claim to advanced design and safety.
The following patents are registered and protected:
US 6,345,553 I US 6,505,530 I EP 1 495 782 I EP 1 618 915 I EP 1 743 673 I EP 1 872 823 I EP 1 958 659 I DE 299 19 199
amiea med® devices have the power to puncture even deeper transepidermal skin layers with adequate needle speed. Their performance is stronger than that of common microneedling pens, which quickly reach their limits in difficult skin conditions.